版权说明 操作指南
首页 > 成果 > 详情

PCSK9/LDLR通路介导姜黄素烟酸酯促进HepG2摄取脂质

认领
导出
Link by 中国知网学术期刊 Link by 万方学术期刊
反馈
分享
QQ微信 微博
成果类型:
期刊论文
作者:
Zhang Cai-Ping;Sun Shao-Wei;Gong Yong-Zhen;Ou Lu;Lin Li-Mei;...
通讯作者:
Liao Duan-Fang
作者机构:
[Zhang Cai-Ping] Univ South China, Coll Med, Hengyang 421001, Peoples R China.
[Lin Li-Mei; Tuo Qin-Hui; Sun Shao-Wei; Gong Yong-Zhen; Liao Duan-Fang] Hunan Univ Chinese Med, State Key Lab Chinese Med Powder & Med Innovat Hu, Div Stem Cell Regulat & Applicat, Changsha 410205, Hunan, Peoples R China.
[Zhang Cai-Ping; Zheng Xing; Sun Shao-Wei; Ou Lu; Lei Xiao-Yong] Univ South China, Coll Pharm & Biol Sci, Hengyang 421001, Peoples R China.
[Tuo Qin-Hui; Gong Yong-Zhen; Liao Duan-Fang] Hunan Univ China, Sinoluxembourg Cooperat Res Ctr Chinese Med, Med, Changsha 410208, Hunan, Peoples R China.
通讯机构:
[Liao Duan-Fang] H
Hunan Univ Chinese Med, State Key Lab Chinese Med Powder & Med Innovat Hu, Div Stem Cell Regulat & Applicat, Changsha 410205, Hunan, Peoples R China.
语种:
中文
关键词:
姜黄素烟酸酯(CurTn);低密度脂蛋白受体(LDLR);低密度脂蛋白(LDL);前蛋白转化酶枯草杆菌蛋白酶9型(PCSK9);胆固醇调节元件结合蛋白2型(SREBP2)
关键词(英文):
CurTn;LDL;LDLR;PCSK9;SREBP2
期刊:
生物化学与生物物理进展
ISSN:
1000-3282
年:
2015
卷:
42
期:
9
页码:
825-832
基金类别:
National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31371161, 81173047]; Natural Science Foundation of Hunan ProvinceNatural Science Foundation of Hunan Province [2015JJ6077, 2014JJ1024]; Construct Program of the Pharmaceutical Science Key Discipline in Hunan Province; Innovation Team in University of South China
机构署名:
本校为第一机构
院系归属:
医学院
药学与生物科学学院
摘要:
为研究PCSK9/LDLR通路介导姜黄素烟酸酯(CurTn)降低血浆低密度脂蛋白胆固醇(LDL-C),减少动脉内膜下脂质沉积的分子机制,用5、10、15 μmo/L姜黄素烟酸酯与25 mg/L LDL共孵育HepG2细胞24 h,分别采用油红O染色、胆固醇荧光定量试剂盒、DiI-LDL摄取检测细胞内胆固醇含量及LDL摄取情况,用逆转录定量聚合酶链反应(RT-Q-PCR)检测LDLR及SREBP2的mRNA表达,蛋白质印迹检测LDLR、SREBP2及PCSK9蛋白表达.随姜黄素烟酸酯作用浓度的增高细胞内脂滴显著增多,细胞内游离胆固醇(FC)、总胆固醇(TC)含量增高,细胞内胆固醇摄取增多;RT-Q-PCR和蛋白质印迹检测发现,与对照组(Control)比较,5、10、15 μmo/L姜黄素烟酸...
摘要(英文):
Low-density lipoprotein cholesterol (LDL-C) is a major risk factor for the atherosclerotic cardiovascular disease (ASCVD). Over 70% of circulating LDL-C is metabolized by binding hepatic LDL receptor (LDLR). Therefore, elevation of LDLR expression would reduce the progression of AS VCD. In order to study the molecular mechanism of Curcumin Nieotinate (CurTn) reducing lipid deposition of arterial intima by lowering plasma LDL-C, HepG2 cells were treated with 5, 10, 15 μmol/L CurTn co-incubated with 25 mg/L LDL for 24 h. Cellular lipid was detec...

反馈

验证码:
看不清楚,换一个
确定
取消

成果认领

标题:
用户 作者 通讯作者
请选择
请选择
确定
取消

提示

该栏目需要登录且有访问权限才可以访问

如果您有访问权限,请直接 登录访问

如果您没有访问权限,请联系管理员申请开通

管理员联系邮箱:yun@hnwdkj.com